NO144830C - SUBSTITUTED CYCLOPENTAND DERIVATIVES FOR USE AS INTERMEDIATE BY PREPARING A PHYSIOLOGY ACTIVE PROSTAGLAND CONNECTION OF THE E OR F SERIES - Google Patents

SUBSTITUTED CYCLOPENTAND DERIVATIVES FOR USE AS INTERMEDIATE BY PREPARING A PHYSIOLOGY ACTIVE PROSTAGLAND CONNECTION OF THE E OR F SERIES

Info

Publication number
NO144830C
NO144830C NO743492A NO743492A NO144830C NO 144830 C NO144830 C NO 144830C NO 743492 A NO743492 A NO 743492A NO 743492 A NO743492 A NO 743492A NO 144830 C NO144830 C NO 144830C
Authority
NO
Norway
Prior art keywords
cyclopentand
prostagland
derivatives
substituted
preparing
Prior art date
Application number
NO743492A
Other languages
Norwegian (no)
Other versions
NO144830B (en
NO743492L (en
Inventor
Michael Ross Johnson
Hans-Jurgen Ernst Hess
Thomas Ken Schaaf
Jasjit Singh Bindra
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of NO743492L publication Critical patent/NO743492L/en
Application filed by Pfizer filed Critical Pfizer
Publication of NO144830B publication Critical patent/NO144830B/en
Publication of NO144830C publication Critical patent/NO144830C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/60Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056Esters of arylalkanephosphonic acids
    • C07F9/4059Compounds containing the structure (RY)2P(=X)-(CH2)n-C(=O)-(CH2)m-Ar, (X, Y = O, S, Se; n>=1, m>=0)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
    • C07F9/655345Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B63SHIPS OR OTHER WATERBORNE VESSELS; RELATED EQUIPMENT
    • B63BSHIPS OR OTHER WATERBORNE VESSELS; EQUIPMENT FOR SHIPPING 
    • B63B2211/00Applications
    • B63B2211/02Oceanography

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
NO743492A 1972-07-13 1974-09-26 SUBSTITUTED CYCLOPENTAND DERIVATIVES FOR USE AS INTERMEDIATE BY PREPARING A PHYSIOLOGY ACTIVE PROSTAGLAND CONNECTION OF THE E OR F SERIES NO144830C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27122072A 1972-07-13 1972-07-13

Publications (3)

Publication Number Publication Date
NO743492L NO743492L (en) 1974-01-15
NO144830B NO144830B (en) 1981-08-10
NO144830C true NO144830C (en) 1981-11-18

Family

ID=23034697

Family Applications (2)

Application Number Title Priority Date Filing Date
NO2724/73A NO143741C (en) 1972-07-13 1973-07-03 ANALOGY PROCEDURE FOR THE PREPARATION OF PHYSIOLOGICALLY ACTIVE PROSTAGLAND CONNECTIONS OF THE E AND F SERIES
NO743492A NO144830C (en) 1972-07-13 1974-09-26 SUBSTITUTED CYCLOPENTAND DERIVATIVES FOR USE AS INTERMEDIATE BY PREPARING A PHYSIOLOGY ACTIVE PROSTAGLAND CONNECTION OF THE E OR F SERIES

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO2724/73A NO143741C (en) 1972-07-13 1973-07-03 ANALOGY PROCEDURE FOR THE PREPARATION OF PHYSIOLOGICALLY ACTIVE PROSTAGLAND CONNECTIONS OF THE E AND F SERIES

Country Status (25)

Country Link
JP (4) JPS5241257B2 (en)
AR (2) AR209064A1 (en)
AT (1) AT367033B (en)
BE (1) BE802231A (en)
CA (1) CA1041495A (en)
CH (1) CH593254A5 (en)
CS (1) CS201027B2 (en)
DD (2) DD109210A5 (en)
DE (1) DE2334945A1 (en)
ES (4) ES416865A1 (en)
FI (1) FI57583C (en)
FR (1) FR2192834B1 (en)
GB (1) GB1446341A (en)
HU (4) HU172058B (en)
IE (1) IE37909B1 (en)
IL (2) IL42691A (en)
IN (1) IN138789B (en)
LU (1) LU68015A1 (en)
NL (1) NL7309792A (en)
NO (2) NO143741C (en)
PH (1) PH11461A (en)
SE (3) SE7705946L (en)
SU (4) SU644384A3 (en)
YU (1) YU187773A (en)
ZA (1) ZA734769B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1386146A (en) * 1972-05-03 1975-03-05 Ici Ltd Cyclopentane derivatives
DE2416193C2 (en) 1974-04-03 1985-08-14 Hoechst Ag, 6230 Frankfurt Prostaglandin analogs, processes for their preparation and their use as cytoprotective agents
DE2463432C2 (en) * 1974-04-03 1987-06-19 Hoechst Ag, 6230 Frankfurt, De
ZA747723B (en) * 1974-12-11 1976-11-24 Pfizer 11-desoxy-15-substituted-omega-pentanor prostaglandins
US4149006A (en) * 1977-01-24 1979-04-10 G. D. Searle & Co. Prostaglandin derivatives having alkynyl, hydroxy and aryloxy junctions in the 2β side chain
GB8329559D0 (en) * 1983-11-04 1983-12-07 Erba Farmitalia Furyl derivatives of 16-substituted prostaglandins preparations
SE9002596D0 (en) * 1990-08-08 1990-08-08 Pharmacia Ab A METHOD OF SYNTHESIS OF PROSTAGLANDIN DERIVATIVES
US5972991A (en) * 1992-09-21 1999-10-26 Allergan Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US6602900B2 (en) 1992-09-21 2003-08-05 Allergan, Inc. Cyclopentane heptan(ENE)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
KR100578616B1 (en) * 2004-07-23 2006-05-10 한미약품 주식회사 Method for the preparation of d-erythro-2,2-difluoro-2-deoxy-1-oxoribose
UA121108C2 (en) * 2013-12-13 2020-04-10 Аллерган, Інк. Solid forms of an alpha, omega di-substituted dihydroxy cyclopentyl compound and methods for the preparation and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1324737A (en) * 1970-11-02 1973-07-25 Upjohn Co Prostaglandins and the preparation thereof
GB1386146A (en) * 1972-05-03 1975-03-05 Ici Ltd Cyclopentane derivatives
IL42373A (en) * 1972-06-02 1977-08-31 Pfizer Oxaprostagliandins and their preparation

Also Published As

Publication number Publication date
IL50308A0 (en) 1976-10-31
GB1446341A (en) 1976-08-18
FI57583C (en) 1980-09-10
JPS5293753A (en) 1977-08-06
SE7705946L (en) 1977-05-20
ZA734769B (en) 1974-06-26
YU187773A (en) 1982-02-25
IL42691A (en) 1979-07-25
SU584791A3 (en) 1977-12-15
JPS52122349A (en) 1977-10-14
SU645563A3 (en) 1979-01-30
AT367033B (en) 1982-05-25
ES437037A1 (en) 1977-01-01
ES437039A1 (en) 1977-01-01
SE7705947L (en) 1977-05-20
AU5778473A (en) 1975-01-09
CA1041495A (en) 1978-10-31
FI57583B (en) 1980-05-30
HU171156B (en) 1977-11-28
DE2334945A1 (en) 1974-03-07
IE37909L (en) 1974-01-13
NO143741B (en) 1980-12-29
FR2192834B1 (en) 1979-04-06
AR209064A1 (en) 1977-03-31
HU171158B (en) 1977-11-28
HU171946B (en) 1978-04-28
JPS5241257B2 (en) 1977-10-17
LU68015A1 (en) 1974-01-21
CH593254A5 (en) 1977-11-30
NO143741C (en) 1981-04-08
NL7309792A (en) 1974-01-15
IE37909B1 (en) 1977-11-09
ATA620773A (en) 1981-10-15
FR2192834A1 (en) 1974-02-15
DD116459A5 (en) 1975-11-20
JPS5297958A (en) 1977-08-17
SU644384A3 (en) 1979-01-25
ES416865A1 (en) 1976-03-01
HU172058B (en) 1978-05-28
IL42691A0 (en) 1973-10-25
SE7705945L (en) 1977-05-20
AR214383A1 (en) 1979-06-15
JPS4992053A (en) 1974-09-03
CS201027B2 (en) 1980-10-31
NO144830B (en) 1981-08-10
ES437038A1 (en) 1977-01-01
IN138789B (en) 1976-04-03
PH11461A (en) 1978-02-01
SU645564A3 (en) 1979-01-30
NO743492L (en) 1974-01-15
BE802231A (en) 1974-01-14
DD109210A5 (en) 1974-10-20

Similar Documents

Publication Publication Date Title
NO141752C (en) Substituted acetic acid esters for use as pesticides
SE418080B (en) CFYCLOPROPANCARBOXYLIC ACID ESTERS FOR USE AS INSECTICIDE
SE424864B (en) ISOXANOLD DERIVATIVES FOR USE AS HERBICID
SE422051B (en) ALKYNYLYCYLOPROPANCARBOXYLIC ACID ESTERS FOR USE AS INSECTICIDES
NO143747C (en) CARBOXYAL COOLESTERS OF N-PHOSPHONE METHYLGYLINE FOR USE AS HERBICIDE AGENTS
SE411748B (en) CYCLEOPROPANCARBOXYLIC ACID ESTERS FOR USE AS PESTICIDES
SE398879B (en) 1-AMINOURACILES FOR USE AS HERBICIDES
SE395149B (en) PROCEDURE FOR THE PREPARATION OF DIBENSO-TIEPINYLPIPERAZINE DERIVATIVES
NO144830C (en) SUBSTITUTED CYCLOPENTAND DERIVATIVES FOR USE AS INTERMEDIATE BY PREPARING A PHYSIOLOGY ACTIVE PROSTAGLAND CONNECTION OF THE E OR F SERIES
SE7601868L (en) CARBONITRILES FOR USE AS INTERMEDIATE PRODUCTS
NO792681L (en) 3-CHLORO-7-ALFA-AMINOACYLCEPHALOSPORINE COMPOUNDS FOR USE AS INTERMEDIATE PRODUCTS IN THE PREPARATION OF CEPHALOSPORINE DERIVATIVES
BR7303232D0 (en) DOUBLE RANGE EXTENSIBLE MECHANISM FOR SUSPENSION TANK
NO138728C (en) CHINOXALINE-DI-N-OXYD DERIVATIVES FOR USE AS WEIGHT PROMOTIONARY ADDITIVES
NO740349L (en) Analogous process for the preparation of antibacterial active piperazine derivatives.
SE419762B (en) PROCEDURE FOR THE PREPARATION OF STARCH HYDRAULIC PRODUCTS
NO146280C (en) BIS-TETRAHYDROPYRANYLETERS FOR USE AS INTERMEDIATE FOR PREPARING A PHYSIOLOGY ACTIVE P-BIFENYLESTER OF A PROSTAGLANDIN ANALOGUE OF THE E OR F SERIES
SE422208B (en) CERTAIN STATED HALOGENTRIAZOL DERIVATIVES FOR USE AS FUNGICIDES
SE418293B (en) PROCEDURE FOR THE PREPARATION OF CEPHALOSPORINE COMPOUNDS WITH A CARBAMOYLOXIMETHYL SUBSTITUENT
SE405064B (en) USE OF ISOMALTITOL AS A CALORIOUS CLEANER
NO791507L (en) COMPOUNDS OF USE AS INTERMEDIATE PRODUCTS FOR THE MANUFACTURE OF THERAPEUTIC ACTIVITIES 4-AMINOAMPHETAMIN DERIVATIVES
NO137597C (en) XANTONE DERIVATIVES FOR USE AS INTERMEDIATE PREPARATIONS
NO145434C (en) 5-CYCLOHEXYL-1-INDANOL FOR USE AS BASIC MATERIAL FOR PREPARATION OF 5-CYCLOHEXYLINDAN COMPOUNDS
SE416790B (en) HAND FOR VESSELS PROVIDED BY TWO PROPELLERS
AR205083A1 (en) PROCEDURE FOR THE PREPARATION OF SULFON SALTS OF 2-5-DIHYDROXY BENZENOSULPHONIC ACIDS
SE403915B (en) USE OF CHLORO-S-TRIAZINE DERIVATIVES AS ACTIVATIVES FOR A PEROXIDE INQUIRY